等待開盤 09-20 09:30:00 美东时间
+0.160
+0.53%
近日,由知名生物技术投资者Oleg Nodelman管理的生物技术对冲基金Ecor1 Capital已将其在比利时制药商Galapagos NV的持股比例增至...
08-28 09:20
Galapagos (NASDAQ:GLPG) shares are up ~10% in Monday trading after a large shareholder in the company said it believes the company is undervalued and wants to talk to management and the board about pe...
08-27 00:41
U.S. stocks were mostly higher, with the Dow Jones index gaining around 150 poi...
08-26 21:59
Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) rose sharply in today's pre-...
08-26 17:58
Galapagos (NASDAQ:GLPG) shares traded higher in Europe on Friday after the U.S. Food and Drug Administration (FDA) greenlighted a Phase 1/2 trial for its CAR-T cell therapy, GLPG5101, in non-Hodgkin l...
08-23 18:53
Jason Gerberry, an analyst from Bank of America Securities, reiterated the Sell...
08-04 22:23
Galapagos (NASDAQ:GLPG) said it has paused enrollment in a Phase 1/2 study of its therapy candidate GLPG5301 after a case of Parkinsonism was observed. The Belgium-based biotech company said in its e...
08-03 03:05
Reversing modest gains recorded in the previous session following the company’s Q2 results, Galapagos (NASDAQ:GLPG) shares turned lower on Friday as Raymond James downgraded the Belgian biotech, citin...
08-03 01:58
In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating o...
08-02 23:56
Galapagos press release (NASDAQ:GLPG): 1H GAAP EPS of €1.51. Revenue of €140.3M (+18.3% Y/Y). More on Galapagos Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript Adaptimmune, Galapagos to collabora...
08-02 04:51